Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial.
Hess CN, Daffron A, Nehler MR, Szarek M, Cannon CP, Hsia J, Saseen JJ, Bonaca MP. Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial. Vasc Med. 2025 Jun; 30(3):321-323.